Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

1.75
Delayed Data
As of Aug 30
 0.00 / 0.00%
Today’s Change
1.08
Today|||52-Week Range
3.25
+6.71%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.75
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)119,708
Market cap$50.1M
Dividend yield--
Data as of 08/30/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+9.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.82

Competitors

 Today’s
change
Today’s
% change
TTHITransition Therapeut...+0.00+0.32%
CALACalithera Bioscience...+0.02+0.63%
CGIXCancer Genetics Inc0.000.00%
ERBERBA Diagnostics Inc-0.07-9.08%
Data as of 08/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

Search for Jobs